• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Genworth Financial Announces Fourth Quarter 2025 Results

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance
    Finance
    Get the next $ACT alert in real time by email

    Strategic Highlights

    • Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025
    • Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States
    • Closed acquisition of Seniorly, Inc. for total cash consideration of $15M
    • Care Assurance launched in October and was live in 39 states as of December 31, 2025
    • Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4

    Financial Highlights

    • Net income5 of $223M, or $0.54 per diluted share, and adjusted operating income5,6 of $144M, or $0.356 per diluted share in 2025
    • Net income5 of $2M and adjusted operating income5,6 of $8M in the quarter
    • Enact reported adjusted operating income of $146M5 in the quarter; distributed $127M in capital returns to Genworth, PMIERs sufficiency ratio7 remains strong at 162%8
    • Completed Closed Block9 annual assumption updates with net unfavorable impacts of $6M to the adjusted operating loss in the quarter
    • Legacy insurance companies'10 RBC ratio11 of 300%8 and statutory pre-tax income of $71M8 in 2025
    • Genworth holding company cash and liquid assets of $234M12 at quarter-end

    Genworth Financial, Inc. (NYSE:GNW) today reported results for the quarter ended December 31, 2025.

    "Genworth delivered strong results in 2025 as we continued to execute against our strategic priorities," said Tom McInerney, President & CEO. "We took major steps to advance CareScout's strategy, with nationwide expansion of the CareScout Quality Network, the launch of Care Plans, our new innovative consumer-facing solution, along with the launch and continued buildout of our CareScout insurance offerings. With Enact as a durable source of cash flows, a growing and increasingly integrated CareScout platform, and disciplined management of our legacy insurance businesses, we are delivering long-term value for shareholders while supporting millions of families navigating the aging journey."

    Consolidated Metrics

    (Amounts in millions, except per share data)

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    Net income (loss)5

     

    $

    2

     

    $

    116

     

    $

    (1

    )

    Net income (loss) per diluted share5

     

    $

    —

     

    $

    0.28

     

    $

    —

     

    Adjusted operating income (loss)5,6

     

    $

    8

     

    $

    17

     

    $

    15

     

    Adjusted operating income (loss) per diluted share5,6

     

    $

    0.02

     

    $

    0.04

     

    $

    0.04

     

    Weighted-average diluted shares13

     

     

    396.4

     

     

    413.3

     

     

    431.0

     

    Consolidated GAAP Financial Highlights

    • Beginning in the fourth quarter of 2025, the company changed its reportable segments to better align with how it currently manages the business. Under the new reporting structure, the company operates its business through the following two reportable segments: Enact, comprised primarily of private mortgage insurance products, and Closed Block, comprised of long-term care insurance, life insurance and annuity products that were previously sold under the legacy insurance companies. Financial information has been updated for all periods
    • Net income was driven by Enact, which had strong operating performance
    • Net investment income, net of taxes, was $620 million in the quarter, down from $631 million in the prior quarter and $626 million in the prior year primarily from lower income from limited partnerships
    • Net investment losses, net of taxes, decreased net income by $31 million in the quarter, compared with net investment gains of $78 million in the prior quarter and net investment losses of $32 million in the prior year. The investment losses in the current quarter were driven primarily by net trading losses and mark-to-market adjustments on limited partnerships

    Enact

    GAAP Operating Metrics

    (Dollar amounts in millions)

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    Adjusted operating income (loss)5

     

    $

    146

     

     

    $

    134

     

     

    $

    137

     

    Primary new insurance written

     

    $

    14,386

     

     

    $

    14,048

     

     

    $

    13,266

     

    Loss ratio

     

     

    7

    %

     

     

    15

    %

     

     

    10

    %

    Equity14

     

    $

    4,351

     

     

    $

    4,320

     

     

    $

    4,068

     

    • Results included a pre-tax net reserve release of $60 million reflecting favorable cure performance and the lowering of claim rate expectations. The prior quarter and prior year included pre-tax reserve releases of $45 million and $56 million, respectively
    • Pre-tax net investment income of $69 million was up from $62 million in the prior year from higher yields and higher invested assets
    • Primary insurance in-force increased 2% versus the prior year to $273.1 billion driven by new insurance written (NIW) and continued elevated persistency
    • Primary NIW was up 2% from the prior quarter and 8% from the prior year

    Capital Metric

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    PMIERs sufficiency ratio7,8

     

    162%

     

    162%

     

    167%

    • In February 2026, Enact announced a new share repurchase program with authorization to purchase up to $500 million of common stock
    • Enact announced an excess of loss reinsurance agreement covering the 2027 book year
    • Enact paid a quarterly dividend of $0.21 per share
    • Estimated PMIERs sufficiency ratio of 162%, $1,919 million above requirements

    Closed Block

    GAAP Adjusted Operating Income (Loss)

    (Amounts in millions)

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    Long-term care insurance

     

    $

    (159

    )

     

    $

    (100

    )

     

    $

    (104

    )

    Life insurance

     

     

    13

     

     

     

    (15

    )

     

     

    2

     

    Annuities

     

     

    32

     

     

     

    19

     

     

     

    3

     

    Total Closed Block

     

    $

    (114

    )

     

    $

    (96

    )

     

    $

    (99

    )

    Long-term care insurance

    • Current quarter loss included unfavorable A/E15 of $124 million pre-tax primarily from higher claims and lower terminations and an unfavorable impact from assumption updates of $47 million pre-tax
    • Unfavorable assumption updates in the current quarter were primarily related to benefit utilization and healthy life mortality and incidence updates that align with near-term experience, largely offset by updates reflecting favorable approval experience and benefit reductions and claim termination rates
    • Prior quarter loss included unfavorable A/E of $107 million pre-tax primarily from lower terminations and higher benefit utilization
    • Prior year loss included unfavorable A/E of $97 million pre-tax primarily from lower terminations and higher claims and an unfavorable impact from assumption updates of $20 million pre-tax

    Life insurance

    • Current quarter income reflects favorable interest rate assumption updates of $15 million pre-tax
    • Prior year included a net favorable impact of $30 million pre-tax from a model refinement and assumption updates

    Annuities

    • Current quarter income reflects favorable impact from annual assumption updates of $25 million pre-tax primarily related to mortality compared to unfavorable updates of $18 million pre-tax in the prior year

    Corporate and Other

    • The current quarter adjusted operating loss was $24 million, up from $21 million in the prior quarter and $23 million in the prior year primarily driven by continued investment in CareScout and debt service, partially offset by favorable tax-related items

    Legacy Insurance Companies10 Statutory Results8 and RBC Ratio8

    (Dollar amounts in millions)

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    Statutory pre-tax income (loss)8,16

     

    $

    3

     

     

    $

    (12

    )

     

    $

    (33

    )

    Long-term care insurance

     

     

    (84

    )

     

     

    (75

    )

     

     

    (78

    )

    Life insurance

     

     

    60

     

     

     

    (2

    )

     

     

    49

     

    Annuities

     

     

    27

     

     

     

    65

     

     

     

    (4

    )

    GLIC consolidated RBC ratio8,11

     

     

    300

    %

     

     

    303

    %

     

     

    306

    %

    • Statutory pre-tax income was $71 million in 2025, with $3 million in the current quarter
      • LTC continued to benefit from premium increases and benefit reductions from IFAs. Results reflected higher claims and lower reserve releases from in-force rate actions, largely offset by higher income from limited partnerships than the prior quarter. The current quarter included an unfavorable $12 million pre-tax impact from assumption updates; prior year included a $79 million increase in cash flow testing reserves in GLICNY, partially offset by a net $20 million pre-tax benefit from assumption updates
      • Life insurance results included a net benefit from assumption updates of $51 million compared to $75 million in the prior year and favorable reserve changes from block runoff
      • Annuity results reflected favorable net equity market and interest rate impacts and unfavorable assumption updates, though lower than the prior year
    • Current quarter estimated GLIC consolidated RBC ratio was 300%, down from the prior year driven by higher required capital as the limited partnership portfolio grows, partially offset by statutory earnings in the year.

    Holding Company Cash and Liquid Assets

    (Amounts in millions)

     

    Q4 2025

     

    Q3 2025

     

    Q4 2024

    Holding company cash and liquid assets12,17

     

    $

    234

     

    $

    254

     

    $

    294

    • Cash and liquid assets were $234 million at the end of the current quarter, which included approximately $127 million of cash held for future obligations, including advance cash payments from the company's subsidiaries
    • Cash inflows during the current quarter included $127 million from Enact capital returns
    • Current quarter cash outflows included $96 million18 in share repurchases, $22 million in net tax payments, $18 million related to debt servicing costs and the repurchase of $7 million in principal of holding company debt at a discount

    Capital Allocation and Shareholder Returns

    • Executed $94 million in share repurchases in the quarter at an average price of $8.66 per share
    • Executed $790 million in share repurchases since the program's inception through December 31, 2025 at an average price of $6.21 per share

    About Genworth Financial

    Genworth Financial, Inc. (NYSE:GNW) is a publicly traded holding company headquartered in Richmond, Virginia. Through its family of brands—including CareScout, Genworth, and Enact—Genworth uses its more than 150 years of experience to help families navigate the aging journey with clarity and confidence, offering guidance, products, and services that support caregiving decisions, long-term care planning, and the financial challenges of aging. Genworth is the majority owner of Enact Holdings, Inc. (NASDAQ:ACT), a leading U.S. mortgage insurance provider. For more information, visit https://www.genworth.com.

    Conference Call Information

    Investors are encouraged to read this press release, summary presentation and financial supplement which are now posted on the company's website, https://investor.genworth.com.

    Genworth will conduct a conference call on February 24, 2026 at 9:00 a.m. (ET) to discuss its fourth quarter results, which will be accessible via:

    • Telephone: 800-330-6710 or 213-279-1505 (outside the U.S.); conference ID # 5373572; or
    • Webcast: https://investor.genworth.com/news-events/ir-calendar

    Allow at least 15 minutes prior to the call time to register for the call. A replay of the webcast will be available on the company's website for one year.

    Use of Non-GAAP Measures

    Management evaluates performance and allocates resources based on a non-GAAP financial measure entitled "adjusted operating income (loss)." Management evaluates adjusted operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. GLIC and its subsidiaries, which comprise the Closed Block segment, are managed on a standalone basis; therefore, the company does not allocate capital to its Closed Block segment.

    The company defines adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of the company's net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to the company's discretion and are influenced by market opportunities, as well as asset-liability matching considerations. The company excludes net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in the company's opinion, they are not indicative of overall operating performance.

    While some of these items may be significant components of net income (loss) determined in accordance with GAAP, the company believes that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with GAAP. In addition, the company's definition of adjusted operating income (loss) may differ from the definitions used by other companies.

    Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% current tax rate, plus any associated deferred taxes, and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.

    The table at the end of this press release provides a reconciliation of net income (loss) available to Genworth Financial, Inc.'s common stockholders to adjusted operating income (loss) for the three and twelve months ended December 31, 2025 and 2024, as well as the three months ended September 30, 2025 and reflects adjusted operating income (loss) as determined in accordance with accounting guidance related to segment reporting.

    Statutory Accounting Data

    The company presents certain supplemental statutory data for GLIC and its consolidating life insurance subsidiaries that has been prepared on the basis of statutory accounting principles (SAP). GLIC and its consolidating life insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners that are prepared using SAP, an accounting basis either prescribed or permitted by such authorities. Due to differences in methodology between SAP and GAAP, the values for assets, liabilities and equity, and the recognition of income and expenses, reflected in financial statements prepared in accordance with GAAP are materially different from those reflected in financial statements prepared under SAP. This supplemental statutory data should not be viewed as an alternative to, or used in lieu of, GAAP.

    This supplemental statutory data includes the company action level RBC ratio for GLIC and its consolidating life insurance subsidiaries as well as combined statutory pre-tax earnings from the principal legacy insurance companies, GLIC, GLAIC and GLICNY. Statutory pre-tax earnings represent the net gain from operations, including the impact from in-force rate actions, before dividends to policyholders, refunds to members and federal income taxes and before realized capital gains or (losses). The combined product level statutory pre-tax earnings are grouped on a consistent basis as those provided on page six of the statutory Annual Statements. Management uses and provides this supplemental statutory data because it believes it provides a useful measure of, among other things, statutory pre-tax earnings and the adequacy of capital. Management uses this data to measure against its policy to manage the legacy insurance companies with internally generated capital.

    Cautionary Note Regarding Forward-Looking Statements

    This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by words such as "expects," "intends," "anticipates," "plans," "believes," "seeks," "estimates," "will," "may" or words of similar meaning and include, but are not limited to, statements regarding the outlook for the company's future business and financial performance. Examples of forward-looking statements include statements the company makes relating to potential dividends or share repurchases; future return of capital by Enact Holdings, Inc. (Enact Holdings), including share repurchases, and quarterly and special dividends; the cumulative economic benefit of approved and future rate increases and benefit reductions included in the multi-year in-force rate action plan and other reduced benefit options associated with the long-term care insurance products in the company's Closed Block segment; planned investments in and the company's outlook for new lines of business or new insurance and other products and services, such as those it is pursuing with its CareScout business (CareScout), including through its CareScout services business (CareScout Services) and its CareScout insurance business (CareScout Insurance); the expected benefits and/or synergies of the Seniorly, Inc. (Seniorly) acquisition; future financial performance, including the expectation that quarterly adverse variances between actual and expected experience could persist resulting in future remeasurement losses in the company's long-term care insurance products in its Closed Block segment; the resolution of the appeal or any potential litigation recovery amounts in connection with the AXA S.A. (AXA) and Santander Cards UK Limited (Santander) litigation, and Genworth's planned use of proceeds from any recovery in connection with the litigation, including share repurchases, debt repurchases and investments in new businesses; future financial condition and liquidity of the company's businesses; and statements the company makes regarding the outlook of the U.S. economy.

    Forward-looking statements are based on management's current expectations and assumptions, which are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Actual outcomes and results may differ materially from those in the forward-looking statements due to global political, economic, inflation, business, competitive, market, regulatory and other factors and risks, including but not limited to, the following:

    • the inability to successfully launch new lines of business, including long-term care insurance and other products and services the company is pursuing with CareScout;
    • the company's failure to maintain the self-sustainability of its legacy insurance subsidiaries, including as a result of the inability to achieve desired levels of in-force management actions and/or the timing of future premium rate increases and associated benefit reductions taking longer to achieve than originally assumed; other regulatory actions negatively impacting the company's life insurance businesses;
    • inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections and/or models, which result in inadequate reserves or other adverse results (including as a result of any changes in connection with quarterly, annual or other reviews);
    • the impact on holding company liquidity caused by an inability to receive dividends or any other returns of capital from Enact Holdings, and limited sources of capital and financing and the need to seek additional capital on unfavorable terms;
    • the impact on any potential recovery in the AXA and Santander litigation resulting from a successful appeal, significant delays or any other adverse development in the litigation;
    • adverse changes to the structure or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac) or the U.S. mortgage insurance market; an increase in the number of loans insured through federal government mortgage insurance programs, including those offered by the Federal Housing Administration; the inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the requirements mandated by PMIERs (or any adverse changes thereto), the inability to meet minimum statutory capital requirements of applicable regulators or the mortgage insurer eligibility requirements of Fannie Mae or Freddie Mac;
    • changes in economic, market and political conditions, labor shortages and fluctuating interest rates; unanticipated financial events, which could lead to market-wide liquidity problems and other significant market disruption resulting in losses, defaults or credit rating downgrades of other financial institutions; deterioration in economic conditions, a recession or a decline in home prices, all of which could be driven by many potential factors, including a U.S. federal government shutdown; an increase in the cost of care impacting the company's long-term care insurance products included in its Closed Block segment; changes in international trade policy, including the potential impact of new or increased tariffs, retaliatory policies or actions from other countries, and trade wars or other events that lead to political and economic instability; changes in government or monetary policies; changes within regulatory agencies; changes in immigration policy; and fluctuations in international securities markets;
    • downgrades in financial strength and credit ratings and potential adverse impacts to liquidity; counterparty credit risks; defaults by counterparties to reinsurance arrangements or derivative instruments; defaults or other events impacting the value of invested assets;
    • changes in tax rates or tax laws, or changes in accounting and reporting standards;
    • litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties;
    • the inability to retain, attract and motivate qualified employees or senior management;
    • changes in the composition of Enact Holdings' business or undue concentration by customer or geographic region;
    • the impact from deficiencies in the company's disclosure controls and procedures or internal control over financial reporting;
    • the occurrence of natural or man-made disasters, including geopolitical tensions and war (including the Russian invasion of Ukraine, instability in the Middle East and economic competition between the United States and China, among others), a public health emergency, including pandemics, or climate change;
    • the inability to effectively manage information technology systems (including artificial intelligence), cyber incidents or other failures, disruptions or security breaches of the company or its third-party vendors, as well as unknown risks and uncertainties associated with artificial intelligence;
    • the inability of third-party vendors to meet their obligations to the company;
    • the lack of availability, affordability or adequacy of reinsurance to protect the company against losses;
    • a decrease in the volume of high loan-to-value home mortgage originations or an increase in the volume of mortgage insurance cancellations;
    • unanticipated claims resulting from Enact Holdings' delegated underwriting and loss mitigation programs;
    • the impact of medical advances such as genetic research and diagnostic imaging, emerging new technology, including artificial intelligence and related legislation; and
    • other factors described in the risk factors contained in Item 1A of the company's Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on February 28, 2025.

    The company provides additional information regarding these risks and uncertainties in its Annual Report on Form 10-K. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Accordingly, for the foregoing reasons, the company cautions the reader against relying on any forward-looking statements. The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required under applicable securities laws.

    Condensed Consolidated Statements of Income (Loss)

    (Amounts in millions, except per share amounts)

     

     

    Three months ended

    December 31,

     

    Twelve months ended

    December 31,

    Three months

    ended

    September 30,

    2025

     

     

    2025

     

     

     

    2024

     

     

    2025

     

     

    2024

     

     

     

    (Unaudited)

     

    (Unaudited)

     

    (Unaudited)

     

     

     

    (Unaudited)

    Revenues:

     

     

     

     

     

     

     

     

     

    Premiums

    $

    886

     

     

    $

    876

     

     

    $

    3,499

     

    $

    3,480

     

     

    $

    886

     

    Net investment income

     

    785

     

     

     

    793

     

     

     

    3,125

     

     

    3,160

     

     

     

    799

     

    Net investment gains (losses)

     

    (39

    )

     

     

    (41

    )

     

     

    59

     

     

    13

     

     

     

    99

     

    Policy fees and other income

     

    152

     

     

     

    154

     

     

     

    618

     

     

    642

     

     

     

    151

     

    Total revenues

     

    1,784

     

     

     

    1,782

     

     

     

    7,301

     

     

    7,295

     

     

     

    1,935

     

    Benefits and expenses:

     

     

     

     

     

     

     

     

     

    Benefits and other changes in policy reserves

     

    1,182

     

     

     

    1,199

     

     

     

    4,821

     

     

    4,766

     

     

     

    1,227

     

    Liability remeasurement (gains) losses

     

    143

     

     

     

    88

     

     

     

    313

     

     

    153

     

     

     

    106

     

    Changes in fair value of market risk benefits and associated hedges

     

    (4

    )

     

     

    (3

    )

     

     

    3

     

     

    (13

    )

     

     

    (1

    )

    Interest credited

     

    97

     

     

     

    101

     

     

     

    386

     

     

    453

     

     

     

    96

     

    Acquisition and operating expenses, net of deferrals

     

    265

     

     

     

    253

     

     

     

    1,009

     

     

    977

     

     

     

    259

     

    Amortization of deferred acquisition costs and intangibles

     

    57

     

     

     

    62

     

     

     

    231

     

     

    249

     

     

     

    57

     

    Interest expense

     

    26

     

     

     

    27

     

     

     

    105

     

     

    115

     

     

     

    27

     

    Total benefits and expenses

     

    1,766

     

     

     

    1,727

     

     

     

    6,868

     

     

    6,700

     

     

     

    1,771

     

    Income (loss) from continuing operations before income taxes

     

    18

     

     

     

    55

     

     

     

    433

     

     

    595

     

     

     

    164

     

    Provision (benefit) for income taxes

     

    4

     

     

     

    20

     

     

     

    84

     

     

    158

     

     

     

    9

     

    Income (loss) from continuing operations

     

    14

     

     

     

    35

     

     

     

    349

     

     

    437

     

     

     

    155

     

    Income (loss) from discontinued operations, net of taxes

     

    21

     

     

     

    (5

    )

     

     

    1

     

     

    (10

    )

     

     

    (8

    )

    Net income (loss)

     

    35

     

     

     

    30

     

     

     

    350

     

     

    427

     

     

     

    147

     

    Less: net income (loss) attributable to noncontrolling interests

     

    33

     

     

     

    31

     

     

     

    127

     

     

    128

     

     

     

    31

     

    Net income (loss) available to Genworth Financial, Inc.'s common stockholders

    $

    2

     

     

    $

    (1

    )

     

    $

    223

     

    $

    299

     

     

    $

    116

     

    Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:

     

     

     

     

     

     

     

     

     

    Basic

    $

    (0.05

    )

     

    $

    0.01

     

     

    $

    0.54

     

    $

    0.71

     

     

    $

    0.30

     

    Diluted

    $

    (0.05

    )

     

    $

    0.01

     

     

    $

    0.54

     

    $

    0.70

     

     

    $

    0.30

     

    Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share:

     

     

     

     

     

     

     

     

     

    Basic

    $

    —

     

     

    $

    —

     

     

    $

    0.54

     

    $

    0.69

     

     

    $

    0.29

     

    Diluted

    $

    —

     

     

    $

    —

     

     

    $

    0.54

     

    $

    0.68

     

     

    $

    0.28

     

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

     

    Basic

     

    396.4

     

     

     

    425.3

     

     

     

    409.0

     

     

    433.9

     

     

     

    408.0

     

    Diluted13

     

    396.4

     

     

     

    431.0

     

     

     

    414.0

     

     

    439.4

     

     

     

    413.3

     

    Reconciliation of Net Income (Loss) to Adjusted Operating Income (Loss)

    (Amounts in millions, except per share amounts)

    (Unaudited)

     

     

    Three months ended

    December 31,

     

    Twelve months ended

    December 31,

    Three months

    ended

    September 30,

    2025

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

     

    Net income (loss) available to Genworth Financial, Inc.'s common stockholders

    $

    2

     

     

    $

    (1

    )

     

    $

    223

     

     

    $

    299

     

     

    $

    116

     

    Add: net income (loss) attributable to noncontrolling interests

     

    33

     

     

     

    31

     

     

     

    127

     

     

     

    128

     

     

     

    31

     

    Net income (loss)

     

    35

     

     

     

    30

     

     

     

    350

     

     

     

    427

     

     

     

    147

     

    Less: income (loss) from discontinued operations, net of taxes

     

    21

     

     

     

    (5

    )

     

     

    1

     

     

     

    (10

    )

     

     

    (8

    )

    Income (loss) from continuing operations

     

    14

     

     

     

    35

     

     

     

    349

     

     

     

    437

     

     

     

    155

     

    Less: net income (loss) from continuing operations attributable to noncontrolling interests

     

    33

     

     

     

    31

     

     

     

    127

     

     

     

    128

     

     

     

    31

     

    Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders

     

    (19

    )

     

     

    4

     

     

     

    222

     

     

     

    309

     

     

     

    124

     

    Adjustments to income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders:

     

     

     

     

     

     

     

     

     

    Net investment (gains) losses, net19

     

    38

     

     

     

    39

     

     

     

    (62

    )

     

     

    (17

    )

     

     

    (99

    )

    Changes in fair value of market risk benefits attributable to changes in interest rates, equity markets and associated hedges20

     

    (6

    )

     

     

    (24

    )

     

     

    (5

    )

     

     

    (43

    )

     

     

    (3

    )

    (Gains) losses on early extinguishment of debt, net21

     

    (1

    )

     

     

    (2

    )

     

     

    (1

    )

     

     

    2

     

     

     

    —

     

    Expenses related to restructuring

     

    —

     

     

     

    1

     

     

     

    —

     

     

     

    12

     

     

     

    1

     

    Taxes on adjustments22

     

    (4

    )

     

     

    (3

    )

     

     

    (10

    )

     

     

    10

     

     

     

    (6

    )

    Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders

    $

    8

     

     

    $

    15

     

     

    $

    144

     

     

    $

    273

     

     

    $

    17

     

    Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders:

     

     

     

     

     

     

     

     

     

    Enact segment

    $

    146

     

     

    $

    137

     

     

    $

    558

     

     

    $

    585

     

     

    $

    134

     

    Closed Block segment:

     

     

     

     

     

     

     

     

     

    Long-term care insurance

     

    (159

    )

     

     

    (104

    )

     

     

    (326

    )

     

     

    (176

    )

     

     

    (100

    )

    Life insurance

     

    13

     

     

     

    2

     

     

     

    (66

    )

     

     

    (94

    )

     

     

    (15

    )

    Annuities

     

    32

     

     

     

    3

     

     

     

    75

     

     

     

    56

     

     

     

    19

     

    Closed Block segment

     

    (114

    )

     

     

    (99

    )

     

     

    (317

    )

     

     

    (214

    )

     

     

    (96

    )

    Corporate and Other

     

    (24

    )

     

     

    (23

    )

     

     

    (97

    )

     

     

    (98

    )

     

     

    (21

    )

    Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders

    $

    8

     

     

    $

    15

     

     

    $

    144

     

     

    $

    273

     

     

    $

    17

     

    Net income (loss) available to Genworth Financial, Inc.'s common stockholders per share:

     

     

     

     

     

     

     

     

     

    Basic

    $

    —

     

     

    $

    —

     

     

    $

    0.54

     

     

    $

    0.69

     

     

    $

    0.29

     

    Diluted

    $

    —

     

     

    $

    —

     

     

    $

    0.54

     

     

    $

    0.68

     

     

    $

    0.28

     

    Adjusted operating income (loss) available to Genworth Financial, Inc.'s common stockholders per share:

     

     

     

     

     

     

     

     

     

    Basic

    $

    0.02

     

     

    $

    0.04

     

     

    $

    0.35

     

     

    $

    0.63

     

     

    $

    0.04

     

    Diluted

    $

    0.02

     

     

    $

    0.04

     

     

    $

    0.35

     

     

    $

    0.62

     

     

    $

    0.04

     

    Weighted-average common shares outstanding:

     

     

     

     

     

     

     

     

     

    Basic

     

    396.4

     

     

     

    425.3

     

     

     

    409.0

     

     

     

    433.9

     

     

     

    408.0

     

    Diluted13

     

    396.4

     

     

     

    431.0

     

     

     

    414.0

     

     

     

    439.4

     

     

     

    413.3

     

    Footnote Definitions

    1. A match with a home care provider is identified when CareScout validates and approves an invoice from a CareScout Quality Network provider that demonstrates a CareScout member has received services for the first time, and the appropriate discount was applied.
    2. Long-term care insurance.
    3. Multi-year rate action plan.
    4. In-force rate actions.
    5. All references reflect amounts available to Genworth's common stockholders.
    6. This is a financial measure that is not calculated based on U.S. Generally Accepted Accounting Principles (GAAP). See the Use of Non-GAAP Measures section of this press release for additional information.
    7. The Private Mortgage Insurer Eligibility Requirements (PMIERs) sufficiency ratio is calculated as available assets divided by required assets as defined within PMIERs.
    8. Company estimate for the fourth quarter of 2025 due to timing of the preparation and filing of the statutory financial statement(s).
    9. Beginning in the fourth quarter of 2025, the company changed its reportable segments—the Closed Block segment is comprised of long-term care insurance, life insurance and annuity products.
    10. Genworth's legacy insurance companies: GLIC, Genworth Life and Annuity Insurance Company (GLAIC) and Genworth Life Insurance Company of New York (GLICNY).
    11. Risk-based capital ratio based on company action level for Genworth Life Insurance Company (GLIC) consolidated.
    12. Includes approximately $127 million, $145 million and $186 million of cash held for future obligations, including advance cash payments from the company's subsidiaries as of December 31, 2025, September 30, 2025 and December 31, 2024, respectively.
    13. Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of the loss from continuing operations for the three months ended December 31, 2025, the company was required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended December 31, 2025, as the inclusion of shares for performance stock units, restricted stock units and other equity-based awards of 6.0 million would have been antidilutive to the calculation. If the company had not incurred a loss from continuing operations for the three months ended December 31, 2025, dilutive potential weighted-average common shares outstanding would have been 402.4 million.
    14. Reflects Genworth's ownership of equity including accumulated other comprehensive income (loss) and excluding noncontrolling interests of $1,017 million, $1,009 million and $937 million as of December 31, 2025, September 30, 2025 and December 31, 2024, respectively.
    15. Actual variances from expected experience.
    16. Net gain (loss) from operations before dividends to policyholders, refunds to members and federal income taxes for GLIC, GLAIC and GLICNY, and before realized capital gains or (losses).
    17. Holding company cash and liquid assets comprises assets held in Genworth Holdings, Inc. (the issuer of outstanding public debt) which is a wholly-owned subsidiary of Genworth Financial, Inc.
    18. Includes $2 million of share repurchases executed in the third quarter of 2025 but settled in the fourth quarter of 2025.
    19. Net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $1 million and $2 million for the three months ended December 31, 2025 and 2024, respectively, and $3 million and $4 million for the twelve months ended December 31, 2025 and 2024, respectively.
    20. Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(2) million and $(21) million for the three months ended December 31, 2025 and 2024, respectively, $(8) million and $(30) million for the twelve months ended December 31, 2025 and 2024, respectively, and $(2) million for the three months ended September 30, 2025.
    21. (Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the twelve months ended December 31, 2024.
    22. Taxes on adjustments included tax expense (benefits) of $3 million and $(24) million for the three and twelve months ended December 31, 2025, respectively, and $(27) million for the three months ended September 30, 2025 related to a release of a portion of the valuation allowance on certain deferred tax assets.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260223312330/en/

    Investors:

    Christine Jewell

    [email protected]

    Media:

    Evans Mandes

    [email protected]

    Get the next $ACT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACT
    $GNW

    CompanyDatePrice TargetRatingAnalyst
    Genworth Financial Inc
    $GNW
    6/18/2025$9.00Mkt Perform → Outperform
    Keefe Bruyette
    Enact Holdings Inc.
    $ACT
    5/5/2025$39.00Outperform → Mkt Perform
    Keefe Bruyette
    Enact Holdings Inc.
    $ACT
    12/6/2023$29.00Neutral
    UBS
    Enact Holdings Inc.
    $ACT
    11/13/2023$30.00Neutral → Buy
    BofA Securities
    Enact Holdings Inc.
    $ACT
    5/9/2023$25.00 → $27.00Underperform → Neutral
    BofA Securities
    Enact Holdings Inc.
    $ACT
    2/8/2023$25.00 → $26.50Mkt Perform → Outperform
    Keefe Bruyette
    Enact Holdings Inc.
    $ACT
    1/9/2023$24.50Neutral → Underperform
    Credit Suisse
    Enact Holdings Inc.
    $ACT
    9/6/2022$27.00Overweight → Neutral
    JP Morgan
    More analyst ratings

    $ACT
    $GNW
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Pres. & CEO, CareScout Ins. White Andrea Lynn converted options into 21,892 shares and covered exercise/tax liability with 6,076 shares, increasing direct ownership by 2% to 684,071 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:30:00 PM ET
    $GNW
    Life Insurance
    Finance

    EVP & Chief Financial Officer Upton Jerome T covered exercise/tax liability with 9,701 shares and converted options into 36,486 shares, increasing direct ownership by 6% to 454,773 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:29:08 PM ET
    $GNW
    Life Insurance
    Finance

    EVP & Chief Investment Officer Saltzgaber Kelly A covered exercise/tax liability with 6,195 shares and converted options into 21,892 shares, increasing direct ownership by 30% to 68,272 units (SEC Form 4)

    4 - GENWORTH FINANCIAL INC (0001276520) (Issuer)

    2/18/26 4:28:05 PM ET
    $GNW
    Life Insurance
    Finance

    $ACT
    $GNW
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Genworth Financial upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Genworth Financial from Mkt Perform to Outperform and set a new price target of $9.00

    6/18/25 7:44:47 AM ET
    $GNW
    Life Insurance
    Finance

    Enact Holdings downgraded by Keefe Bruyette with a new price target

    Keefe Bruyette downgraded Enact Holdings from Outperform to Mkt Perform and set a new price target of $39.00

    5/5/25 8:29:05 AM ET
    $ACT
    Specialty Insurers
    Finance

    UBS initiated coverage on Enact Holdings with a new price target

    UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00

    12/6/23 7:20:51 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    $GNW
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $ACT
    $GNW
    SEC Filings

    View All

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Enact Reports Fourth Quarter and Full Year 2025 Results

    GAAP Net Income of $177 million, or $1.22 per diluted shareAdjusted Operating Income of $179 million, or $1.23 per diluted shareReturn on Equity of 13.3% and Adjusted Operating Return on Equity of 13.5%Primary Insurance in-force of $273 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $37.66 and Book Value Per Share excluding AOCI of $37.87Returned over $500 million of capital to shareholders in 2025 RALEIGH, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced its fourth quarter and full year 2025 results. "Enact delivered a strong fourth quarter, capping another successful year driv

    2/3/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Enact Announces New $500 Million Share Repurchase Program and $0.21 Per Share Quarterly Dividend

    RALEIGH, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors authorized a new share repurchase program under which the company may purchase up to $500 million of its common stock. The new share repurchase authorization is in addition to the company's current $350 million share repurchase program, of which $30 million remains as of January 30, 2026. Additionally, Enact's Board of Directors declared a quarterly dividend of $0.21 per common share, payable on March 19, 2026, to shareholders of record on February 26, 2026. "The Board's

    2/3/26 4:15:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    SEC Form 8-K filed by Genworth Financial Inc

    8-K - GENWORTH FINANCIAL INC (0001276520) (Filer)

    2/23/26 4:12:34 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SCHEDULE 13G filed by Genworth Financial Inc

    SCHEDULE 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/12/26 9:29:26 AM ET
    $GNW
    Life Insurance
    Finance

    SEC Form 144 filed by Enact Holdings Inc.

    144 - Enact Holdings, Inc. (0001823529) (Subject)

    2/11/26 11:52:54 AM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    $GNW
    Financials

    Live finance-specific insights

    View All

    Genworth Financial Announces Fourth Quarter 2025 Results

    Strategic Highlights Executed $94M in share repurchases in the quarter; $245M in 2025 and $790M since program inception as of December 31, 2025 Delivered 925 matches with home care providers1 in the CareScout Quality Network in the quarter with over 95% home care coverage of the aged 65-plus census population in the United States Closed acquisition of Seniorly, Inc. for total cash consideration of $15M Care Assurance launched in October and was live in 39 states as of December 31, 2025 Continued progress on the LTC2 MYRAP3 with $100M of gross incremental premium approvals in the quarter; approximately $34.5B estimated net present value achieved since 2012 from IFAs4 Financ

    2/23/26 4:10:00 PM ET
    $ACT
    $GNW
    Specialty Insurers
    Finance
    Life Insurance

    Enact Reports Fourth Quarter and Full Year 2025 Results

    GAAP Net Income of $177 million, or $1.22 per diluted shareAdjusted Operating Income of $179 million, or $1.23 per diluted shareReturn on Equity of 13.3% and Adjusted Operating Return on Equity of 13.5%Primary Insurance in-force of $273 billion, a 2% year-over-year increasePMIERs Sufficiency of 162% or approximately $1.9 billionBook Value Per Share of $37.66 and Book Value Per Share excluding AOCI of $37.87Returned over $500 million of capital to shareholders in 2025 RALEIGH, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced its fourth quarter and full year 2025 results. "Enact delivered a strong fourth quarter, capping another successful year driv

    2/3/26 4:20:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    Enact Announces New $500 Million Share Repurchase Program and $0.21 Per Share Quarterly Dividend

    RALEIGH, N.C., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors authorized a new share repurchase program under which the company may purchase up to $500 million of its common stock. The new share repurchase authorization is in addition to the company's current $350 million share repurchase program, of which $30 million remains as of January 30, 2026. Additionally, Enact's Board of Directors declared a quarterly dividend of $0.21 per common share, payable on March 19, 2026, to shareholders of record on February 26, 2026. "The Board's

    2/3/26 4:15:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    $GNW
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Genworth Financial Inc

    SC 13G - GENWORTH FINANCIAL INC (0001276520) (Subject)

    10/25/24 3:16:06 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Genworth Financial Inc (Amendment)

    SC 13G/A - GENWORTH FINANCIAL INC (0001276520) (Subject)

    2/13/24 5:06:12 PM ET
    $GNW
    Life Insurance
    Finance

    SEC Form SC 13G/A filed by Enact Holdings Inc. (Amendment)

    SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)

    2/13/24 4:15:14 PM ET
    $ACT
    Specialty Insurers
    Finance

    $ACT
    $GNW
    Leadership Updates

    Live Leadership Updates

    View All

    Enact Holdings Set to Join S&P SmallCap 600

    NEW YORK, April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE:SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector April 16, 2025 S&P SmallCap 600 Addition Enact Holdings ACT Financials April 16, 2025 S&P SmallCap 600 Deletion SolarWinds SWI Information Technology For more information about S&P Dow Jones Indices, please vi

    4/9/25 5:42:00 PM ET
    $ACT
    $SPGI
    $SWI
    Specialty Insurers
    Finance
    Finance: Consumer Services
    Computer Software: Prepackaged Software

    Enact Announces Changes to its Board of Directors

    RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public

    3/11/25 4:15:00 PM ET
    $ACT
    Specialty Insurers
    Finance

    CareScout, a Genworth Company, Aims to Redefine Quality and Build Trust in Long-Term Care

    CareScout Quality Network brings together providers committed to person-centered care. CareScout today introduced the CareScout Quality Network, a first-of-its-kind group of long-term care providers who meet high standards for quality, person-centered care. "The long-term care industry is ripe for innovation because health and social systems aren't built to support the demand of our rapidly aging population. Older adults and their families are left to navigate a fragmented and confusing experience to find care," said Samir Shah, CEO of CareScout Services. "Quality measures today only meet the lowest common denominator of patient safety, which is important, but provides zero insight into

    2/13/24 8:30:00 AM ET
    $GNW
    Life Insurance
    Finance